Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study

Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study

Bernhard Manger,1 Falk Hiepe,2 Matthias Schneider,3 Margitta Worm,4 Peter Wimmer,5 Eva-Maria Paulus,5 Andreas Schwarting6 1University Hospital Erlangen, Med Clinic III Polyclinic, Erlangen, 2Rheumatology, University Hospital Charité, Campus Mitte, Berlin, 3Policlinic of Rheumatology, Hein...

Full description

Bibliographic Details
Main Authors: Manger B, Hiepe F, Schneider M, Worm M, Wimmer P, Paulus EM, Schwarting A
Format: Article
Language:English
Published: Dove Medical Press 2015-07-01
Series:Clinical and Experimental Gastroenterology
Online Access:http://www.dovepress.com/impact-of-switching-from-mycophenolate-mofetil-to-enteric-coated-mycop-peer-reviewed-article-CEG

Internet

http://www.dovepress.com/impact-of-switching-from-mycophenolate-mofetil-to-enteric-coated-mycop-peer-reviewed-article-CEG

Similar Items